Development of DOCA-salt hypertension in the Brattleboro rat.
D000818:Animals; D001127:Arginine Vasopressin / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology; D003900:Desoxycorticosterone; D003919:Diabetes Insipidus / Q000503:physiopathology*; D004032:Diet; D006973:Hypertension / Q000139:chemically induced* / Q000503:physiopathology; D009392:Nephrectomy; D009994:Osmolar Concentration; D051381:Rats; D011910:Rats, Brattleboro / Q000502:physiology*; D011922:Rats, Mutant Strains / Q000502:physiology*; D012965:Sodium Chloride / Q000008:administration & dosage
D001127:Arginine Vasopressin; D003900:Desoxycorticosterone; D012965:Sodium Chloride; D003894:Deamino Arginine Vasopressin